Abstract Bibliography

Back to Publications
  1. Dimond M, Fiuzat M, Psotka MA, et al. Functional and symptomatic clinical endpoints in heart failure research: insights from the Heart Failure Collaboratory (HFC)–Academic Research Consortium (ARC) scientific expert panel. J Am Coll Cardiol. 2022;79(9)(suppl):256. doi:10.1016/S0735-1097(22)01247-5.
  2. Dimond M, Ibrahim NE, Psotka MA, et al. Is it time to update the classification of heart failure as heart failure with or without evidence of systolic dysfunction? J Am Coll Cardiol. 2022;79(9)(suppl):366. doi:10.1016/S0735-1097(22)01357-2. 
  3. Dimond M, Khan MS, Fiuzat M, et al. Quality of life assessments as inclusion criteria in heart failure clinical trials. Circulation. 2023;148(suppl 1):A12936. doi:10.1161/circ.148.suppl_1.12936.
  4. Dimond MG, Fiuzat M, Mentz RJ, et al. Rewarding site-based research: a step toward improving the ecosystem of heart failure clinical trials. JACC Heart Fail. 2024;12(1):226-228. doi:10.1016/j.jchf.2023.07.032. 
  5. Dimond M, Fabbri M, Fiuzat M, et al. Variation Of Prespecified Subgroups In Large-Scale HF Outcome Trials. J Card Fail. 2024;30(1):202-203. doi:10.1016/j.cardfail.2023.10.209.
  6. Dimond M, Lee SB, Fiuzat M, Francis C Jr, Speir AM, O’Connor CM. Top US cardiology and heart surgery hospitals are under-performing in measures of patient experience. J Am Coll Cardiol. 2023;81(8)(suppl):2196. doi:10.1016/S0735-1097(23)02640-2. 
  7. Dimond M, Shakoor U, Rosner CM, et al. Utilization of guideline directed medical therapy for heart failure in cardiogenic shock survivors: an Inova shock registry analysis. J Am Coll Cardiol. 2023;81(8)(suppl):569. doi:10.1016/S0735-1097(23)01013-6. 
  8. Gupta M, Vardeny O, Ibrahim NE, et al. A call to action: how can Congress help enhance diversity in clinical trials? J Am Coll Cardiol. 2024;83(13)(suppl):726. doi:10.1016/S0735-1097(24)02716-5. 
  9. Cavagna I, Wittes J, Fleming TR, et al. Training the next generation: a novel initiative from the Heart Failure Collaboratory. J Am Coll Cardiol. 2024;83(13)(suppl):543. doi:10.1016/S0735-1097(24)02533-6. 
  10. Evans Y, Fiuzat M, Dimond M, et al. Bridging the gap: the future for diverse clinical trial enrollment utilizing National Pan-Hellenic Councils—an effort from the Heart Failure Collaboratory (HFC). J Am Coll Cardiol. 2024;83(13)(suppl):653. doi:10.1016/S0735-1097(24)02643-3. 
  11. Cavagna I, Adamson PB, Echols MR, et al. Clinical trial inclusion and impact on early adoption of medical innovation in diverse populations: a real-world case study in patients with heart failure. J Am Coll Cardiol. 2024;83(13)(suppl):420. doi:10.1016/S0735-1097(24)02410-0.  
  12. Cavagna I, Lala A, Hamo C, et al. Attempts to achieve standardized definitions to characterize changes in kidney function in the context of heart failure clinical trials: from the Heart Failure Collaboratory. J Card Fail. 2025;31(1):220-221. doi:10.1016/j.cardfail.2024.10.106.
  13. Bhatt A, Hamo C, Fiuzat M, et al. Developing a comprehensive medical therapy score for cardiovascular-kidney-metabolic syndrome: an initiative from the Heart Failure Collaboratory. J Am Coll Cardiol. 2025;85(12)(suppl):1665. doi:10.1016/S0735-1097(25)02149-7.
  14. DeFilippis EM, Blumer V, Leifer E, et al. Collection of social determinants of health in heart failure clinical trials: an initiative of the Heart Failure Collaboratory. J Am Coll Cardiol. 2025;85(12)(suppl):1397. doi:10.1016/S0735-1097(25)01881-9.
  15. De Oliveira Gomes DC, Blumer V, Fiuzat M, et al. Addressing Hispanic underrepresentation in two major heart failure clinical trials: insights from the Heart Failure Collaboratory (HFC). J Am Coll Cardiol. 2025;85(12)(suppl):1646. doi:10.1016/S0735-1097(25)02130-8.
  16. Guilliod CR, Blumer V, O’Connor CM, et al. Barriers to enrollment of women in heart failure clinical trials: insights from the Heart Failure Collaboratory. J Am Coll Cardiol. 2025;85(12)(suppl):1575. doi:10.1016/S0735-1097(25)02059-5.
  17. Guilliod CR, Blumer V, Fiuzat M, et al. Regional disparities in underrepresented minority enrollment in heart failure clinical trials: insights from the Heart Failure Collaboratory (HFC). J Am Coll Cardiol. 2025;85(12)(suppl):1642. doi:10.1016/S0735-1097(25)02126-6.
  18. Chedid El Helou M, Rajendran J, Albert NM, et al. Association of comprehensive guideline-directed medical therapy with clinical outcomes across the heart failure spectrum. J Am Coll Cardiol. 2025;85(12)(suppl):1723. doi:10.1016/S0735-1097(25)02207-7.
  19. Rivera A, Fiuzat M, Carson PE, O’Connor CM. Mode of death in heart failure with reduced ejection fraction: a review of landmark trials from the Heart Failure Collaboratory. J Am Coll Cardiol. 2026;87(13)(suppl A):A641. doi:10.1016/j.jacc.2026.02.1689.